Latest Insider Transactions at Tempest Therapeutics, Inc. (TPST)
This section provides a real-time view of insider transactions for Tempest Therapeutics, Inc. (TPST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tempest Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tempest Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
387,999
-64.89%
|
$387,999
$1.1 P/Share
|
|
Aug 08
2024
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
400,000
-40.08%
|
$400,000
$1.35 P/Share
|
|
Jul 03
2024
|
Stephen R Brady President and CEO |
BUY
Open market or private purchase
|
Direct |
35,000
+43.01%
|
$70,000
$2.11 P/Share
|
|
Jul 02
2024
|
Samuel Whiting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,672
+32.8%
|
$9,344
$2.13 P/Share
|
|
Jun 28
2024
|
Justin Trojanowski Corporate Controller |
BUY
Open market or private purchase
|
Direct |
7,500
+25.28%
|
$15,000
$2.16 P/Share
|
|
Apr 29
2022
|
Thomas Woiwode Director |
BUY
Open market or private purchase
|
Indirect |
2,118,644
+50.0%
|
$4,237,288
$2.36 P/Share
|
|
Jan 07
2022
|
Thomas W. Dubensky President |
BUY
Open market or private purchase
|
Direct |
2,000
+1.73%
|
$8,000
$4.78 P/Share
|
|
Jan 06
2022
|
Samuel Whiting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,700
+47.21%
|
$6,800
$4.8 P/Share
|
|
Jun 25
2021
|
Samuel Whiting Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
201
+50.0%
|
-
|
|
Jun 25
2021
|
Pierre Lorenzo Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
53
+50.0%
|
-
|
|
Jun 25
2021
|
Thomas Woiwode Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,176,411
+50.0%
|
-
|
|
Jun 25
2021
|
Thomas W. Dubensky President |
BUY
Grant, award, or other acquisition
|
Direct |
111,343
+50.0%
|
-
|
|
Jun 25
2021
|
Stella Xu |
BUY
Grant, award, or other acquisition
|
Indirect |
579,710
+50.0%
|
-
|